GSK1562902A
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for GSK1562902A, covering 2013-05-20 to 2020-04-09. Get the full timeline:
Most recent: Clinical Trial Update: Assess Consistency of Immunogenicity of GlaxoSmithKline Biologicals' Pandemic Influenza Vaccine (GSK1562902A) in Adults [Phase 3]